Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fast skeletal troponin complex is a heterotrimeric protein assembly located on the thin filaments of fast-twitch (Type II) skeletal muscle fibers, consisting of troponin C, troponin I, and troponin T subunits (UniProt, 2024). It functions as a calcium-sensitive molecular switch that regulates muscle contraction by controlling the interaction between actin and myosin filaments (Hwee et al., 2017). When calcium binds to the troponin C subunit, the complex undergoes a conformational change that moves tropomyosin away from myosin-binding sites on actin, allowing for cross-bridge cycling and force generation (StatPearls, 2023). This complex is a significant therapeutic target in neuromuscular diseases like amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), where impaired neural signaling leads to muscle weakness (Shefner et al., 2019). Pharmacological agents known as fast skeletal muscle troponin activators (FSTAs), such as reldesemtiv and tirasemtiv, bind to the complex to increase its sensitivity to calcium (Malik et al., 2011). By sensitizing the sarcomere to calcium, these drugs amplify the muscle response to diminished neural input, potentially improving physical function and respiratory capacity in patients with neuromuscular disorders (Andrews et al., 2021).
Fast skeletal muscle troponin activation; calcium sensitization of the sarcomere
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fast skeletal troponin complex (fsTn).